Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW
Clinical trial NCT06095362 · COMPLETED
Trial details
- NCT number
- NCT06095362
- Sponsor
- University Medical Center Groningen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-29
- Primary completion
- 2023-10-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.